Danaher Life Sciences - Anyone else feeling the uncertainty?

Hey everyone, long-time lurker here, finally decided to post. I'm in one of the Danaher Life Sciences divisions, and while there haven't been any official announcements, the vibe has been... tense. There are whispers about restructuring and efficiency drives across a few business units. My team hasn't seen anything concrete, but we're all kind of watching our backs and wondering if we're safe. Has anyone else in LSI experienced anything similar? Are there specific divisions that seem more impacted? I know Danaher is known for its operational excellence, but sometimes that feels like a euphemism for cost-cutting that impacts people. Just trying to get a sense of what's happening beyond our little bubble. Trying not to panic, but it's hard not to when the general market is shaky and there's this underlying buzz.